of the GDP
of adults report delaying or going without care due to costs
from 1980 to 2017
of children aged 19-35 months received combined 7-vaccine series
While pharmaceutical spending growth remains historically low in the United States, a recent IMS Health study finds there was a 3.2% increase in spending on medicines in 2013, a bounce back from the 1.0% decline the previous year. On a …
In its June 2014 issue, “Economics of Health Care: Costs, Savings & Value,” the policy journal Health Affairs examines the potential to rein in spending while simultaneously ensuring access and quality, with a particular focus on Medicare and Medicaid.